Related Experiment Video
Updated: Jul 29, 2025

08:07
A Morphometric and Cellular Analysis Method for the Murine Mandibular Condyle
Published on: January 11, 2018
8.4K
Extracorporealization of the Mandibular Condyle: Effects on Viability and Function.
Max R Emmerling1, Meghan LaVigne2, Gary Warburton3
1Division of Oral and Maxillofacial Surgery, Cook County Health, Chicago, IL, USA.
Craniomaxillofacial Trauma & Reconstruction
|May 24, 2023
Summary
Extra-oral vertical ramus osteotomy (EVRO) with condylar extracorporealization is a viable surgical option for complex condylar fractures. This retrospective study found it effective with acceptable outcomes, despite some minor resorption and temporomandibular joint pain.
Area of Science:
- Oral and Maxillofacial Surgery
- Orthognathic Surgery
- Trauma Surgery
Background:
- Extra-oral vertical ramus osteotomy (EVRO) allows extracorporealization of the condylar segment for complex fractures and osteochondromas.
- Concerns exist regarding the long-term condylar health following this surgical approach.
Purpose of the Study:
- To evaluate the surgical outcomes and long-term viability of condylar extracorporealization using EVRO.
- To assess clinical and radiographic results in patients treated for condylar fractures and osteochondromas.
Main Methods:
- Retrospective analysis of 26 patients undergoing EVRO with condylar extracorporealization.
- Evaluation of clinical outcomes including occlusion, maximum interincisal opening (MIO), facial asymmetry, infection, and temporomandibular joint (TMJ) pain.
- Radiographic assessment for condylar resorption using panoramic imaging.
Main Results:
- Average follow-up was 15.9 months, with average MIO of 36.8 mm.
- Five patients showed mild to moderate condylar resorption; three reported TMJ pain.
- Two malocclusions were linked to concurrent facial fractures, not the EVRO procedure itself.
Conclusions:
- Condylar extracorporealization via EVRO is a feasible treatment for complex condylar fractures when standard methods fail.
- The technique demonstrates acceptable clinical outcomes and viability for specific maxillofacial reconstructive procedures.

